Literature DB >> 8527555

Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS.

M C Meyohas1, P Roux, D Bollens, C Chouaid, W Rozenbaum, J L Meynard, J L Poirot, J Frottier, C Mayaud.   

Abstract

We reviewed the records of 85 patients infected with both human immunodeficiency virus and Cryptococcus neoformans. Twenty-seven patients (32%) had pulmonary cryptococcosis. C. neoformans was cultured from bronchoalveolar lavage (BAL) or pleural fluid in 25 cases; the remaining two patients had cryptococcal antigen (CA) detected in BAL fluid and C. neoformans cultured from other sites. All but one of the 27 patients had detectable CA in serum. The CD4+ lymphocyte count was low in all cases (median, 24/mm3). Clinical manifestations of pulmonary cryptococcosis included fever (94%), cough (71%), dyspnea (7%), expectoration (4%), chest pain (2%), and hemoptysis (1%). Diffuse interstitial opacities (70.5%), focal interstitial abnormalities, alveolar opacities, adenopathies, cavitary lesions, and pleural effusions were evident. Outcome was poor (mean survival time, 23 weeks) despite treatment. Patients with localized pulmonary cryptococcosis appeared to have a higher CD4+ lymphocyte count, an earlier diagnosis, lower serum CA titers, fewer previous or concomitant infections, and a better prognosis than patients with disseminated cryptococcosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8527555     DOI: 10.1093/clinids/21.3.628

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  20 in total

1.  Changes in the pattern of respiratory diseases necessitating hospitalization of HIV-infected patients since the advent of highly active antiretroviral therapy.

Authors:  Véronique Dufour; Jacques Cadranel; Marie Wislez; Armelle Lavole; Emmanuel Bergot; Antoine Parrot; Pierre Rufat; Charles Mayaud
Journal:  Lung       Date:  2004       Impact factor: 2.584

2.  A typical atypical pneumonia.

Authors:  J Mikhael; S Humphrey; M Jabi; Ad Badley
Journal:  Can J Infect Dis       Date:  2002-01

3.  Uncommon mycosis in a patient with diabetes.

Authors:  Kuruswamy Thurai Prasad; Inderpaul Singh Sehgal; M R Shivaprakash; Sahajal Dhooria
Journal:  BMJ Case Rep       Date:  2016-02-25

4.  Utility of routine testing of bronchoalveolar lavage fluid for cryptococcal antigen.

Authors:  S M Kralovic; J C Rhodes
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

5.  Cryptococcosis in HIV negative patients: findings on chest radiography.

Authors:  D J Roebuck; D A Fisher; B J Currie
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

6.  Pulmonary cryptococcosis: imaging findings in 23 non-AIDS patients.

Authors:  Kyoung Doo Song; Kyung Soo Lee; Man Pyo Chung; O Jung Kwon; Tae Sung Kim; Chin A Yi; Myung Jin Chung
Journal:  Korean J Radiol       Date:  2010-06-21       Impact factor: 3.500

Review 7.  Evaluation of respiratory disease.

Authors:  Sofya Tokman; Laurence Huang
Journal:  Clin Chest Med       Date:  2013-04-15       Impact factor: 2.878

Review 8.  Other HIV-associated pneumonias.

Authors:  Jakrapun Pupaibool; Andrew H Limper
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

9.  Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen.

Authors:  Nina Singh; Barbara D Alexander; Olivier Lortholary; Françoise Dromer; Krishan L Gupta; George T John; Ramon del Busto; Goran B Klintmalm; Jyoti Somani; G Marshall Lyon; Kenneth Pursell; Valentina Stosor; Patricia Muñoz; Ajit P Limaye; Andre C Kalil; Timothy L Pruett; Julia Garcia-Diaz; Atul Humar; Sally Houston; Andrew A House; Dannah Wray; Susan Orloff; Lorraine A Dowdy; Robert A Fisher; Joseph Heitman; Marilyn M Wagener; Shahid Husain
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

Review 10.  HIV-associated opportunistic pneumonias.

Authors:  Laurence Huang; Kristina Crothers
Journal:  Respirology       Date:  2009-05       Impact factor: 6.424

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.